Zura Bio ZURA
NASDAQ ZURA
$4.14 -0.02 (-0.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

Zura Bio (ZURA) EBITDA (2024 - 2026)

Updated

Zura Bio (ZURA) recorded EBITDA of -$29.34 million in Q2 2026, compared with -$18.07 million a year earlier.

Analysis

Zura Bio (ZURA) EBITDA (2024 - 2026) Analysis & Trends

On a TTM basis, Zura Bio's EBITDA came in at -$92.7 million as of Jun 30, 2026; for FY2025, it was -$75.2 million.

  • Across earlier years, EBITDA came in at -$55.18 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBITDA in data going back to Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$25.48 million (Q1 2026), -$18.4 million (Q4 2025) and -$19.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.10 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 8.33 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -9.70 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.30 Bn
10 Zura Bio 527.50 Mn 527.50 Mn - -29.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.34 Mn
Mar 31, 2026 -25.48 Mn
Dec 31, 2025 -18.40 Mn
Sep 30, 2025 -19.49 Mn
Jun 30, 2025 -18.07 Mn
Mar 31, 2025 -19.25 Mn
Dec 31, 2024 -15.73 Mn
Sep 30, 2024 -19.32 Mn
API Access

Zura Bio EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ZURA&period=max&api_key=YOUR_API_KEY